EUVIMEDEUVIMED entdecken
Crossref

National adoption of an esophageal cell collection device for Barrett’s esophagus surveillance: impact on delay to investigation and pathological findings

Siobhan Chien iD, Paul Glen, Ian Penman, Gavin Bryce, Neil Cruickshank, Michael Miller, Andrew Crumley, Jonathan Fletcher, Perminder Phull, Ivan Gunjaca, Kevin Robertson, Jeyakumar Apollos und 2 weitere

Diseases of the Esophagus · 2024

DOI: 10.1093/dote/doae002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases of the Esophagus, 2024. Verfasst von Siobhan Chien und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Sustainable Delivery, Golden Jubilee National Hospital, Clydebank, Glasgow G81 4DN, UK. Hauptthemen laut MEDLINE: Barrett Esophagus, Esophageal Neoplasms, Esophagoscopy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High quality Barrett’s esophagus surveillance is crucial to detect early neoplastic changes. An esophageal cell collection device (OCCD) was introduced as a triage tool for Barrett’s surveillance. This study aims to evaluate whether the Scottish OCCD program (CytoSCOT) has reduced delays to Barrett’s surveillance, and whether delayed surveillance negatively impacts endoscopic pathology. All patients undergoing OCCD testing for Barrett’s surveillance across 11 Scottish health boards between 14/9/2020 and 13/9/2022 were identified. Patients were dichotomised into two groups (Year 1 vs. Year 2), with individual records interrogated to record demographics, recommended surveillance interval, time from last endoscopy to OCCD test, and OCCD result. Patients were deemed high-risk if the OCCD demonstrated atypia and/or p53 positivity. Further analysis was performed on patients who underwent endoscopy within 12 months of OCCD testing. A total of 3223 OCCD tests were included in the analysis (1478 in Year 1; 1745 in Year 2). In Year 1 versus Year 2, there was a longer median delay to surveillance (9 vs. 5 months; P < 0.001), increased proportion of patients with delayed surveillance (72.6% vs. 57.0%; P < 0.001), and more high-risk patients (12.0% vs. 5.3%; P < 0.001). 425/3223 patients (13.2%) were further investigated with upper gastrointestinal endoscopy, 57.9% of which were high-risk. As surveillance delay increased beyond 24 months, high-risk patients were significantly more likely to develop dysplasia or malignancy (P = 0.004). Delayed Barrett’s esophagus surveillance beyond 24 months is associated with increased risk of pre-cancerous pathology. The CytoSCOT program has reduced delays in surveillance, promoting earlier detection of dysplasia and reducing burden on endoscopy services.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Barrett EsophagusEsophageal NeoplasmsEsophagoscopyHumansMaleFemaleMiddle AgedAgedScotlandTime FactorsEarly Detection of CancerEsophagusDelayed DiagnosisPrecancerous ConditionsAdenocarcinoma

Stichwörter der Autor:innen

Barrett’s esophaguscancer screeningdysplasiaearly esophageal cancer

Autor:innen und Institutionen

  • Centre for Sustainable Delivery, Golden Jubilee National Hospital, Clydebank, Glasgow G81 4DN, UK.
  • School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1QH, UK.
  • Department of General Surgery, Queen Elizabeth University Hospital, Glasgow G51 4TF, UK.
  • Centre for Liver & Digestive Disorders, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK.
  • Department of General Surgery, University Hospital Wishaw, Wishaw ML2 0DP, UK.
  • Department of General Surgery, Victoria Hospital, Kirkcaldy KY2 5AH, UK.

ORCID-Profile: Siobhan Chien

Zitieren

APA

Chien, S., Glen, P., Penman, I., Bryce, G., Cruickshank, N., Miller, M., Crumley, A., Fletcher, J., Phull, P., Gunjaca, I., Robertson, K., Apollos, J., Fullarton, G., & CytoSCOT group (2024). National adoption of an esophageal cell collection device for Barrett’s esophagus surveillance: impact on delay to investigation and pathological findings. Diseases of the Esophagus. https://doi.org/10.1093/dote/doae002

Vancouver

Chien S, Glen P, Penman I, Bryce G, Cruickshank N, Miller M, et al. National adoption of an esophageal cell collection device for Barrett’s esophagus surveillance: impact on delay to investigation and pathological findings. Diseases of the Esophagus. 2024. doi:10.1093/dote/doae002

BibTeX
@article{Chien2024,
  author = {Chien, Siobhan and Glen, Paul and Penman, Ian and Bryce, Gavin and Cruickshank, Neil and Miller, Michael and Crumley, Andrew and Fletcher, Jonathan and Phull, Perminder and Gunjaca, Ivan and Robertson, Kevin and Apollos, Jeyakumar and Fullarton, Grant and CytoSCOT group, CytoSCOT group},
  title = {National adoption of an esophageal cell collection device for Barrett’s esophagus surveillance: impact on delay to investigation and pathological findings},
  journal = {Diseases of the Esophagus},
  year = {2024},
  doi = {10.1093/dote/doae002}
}
Kostenlos starten →